M. Matschke et al. / Tetrahedron 64 (2008) 7815–7821
7821
2.8–3.0 (m, 4H), 6.85 (t, 3J¼6.5 Hz, 1H), 6.87 (t, 3J¼6.5 Hz, 1H), 7.06
(d, 3J¼4.8 Hz, 1H), 7.15–7.20 (m, 3H), 7.23–7.30 (m, 3H), 7.34–7.40
(ATR): 1643, 1612, 1583, 1551, 1494, 1467 cmꢀ1; UV–vis (CHCl3) lmax
(log 3): 272 (4.4), 457 (3.9), 502 (4.0), 534 (3.9) nm; CV:
(m, 2H); 13C NMR (100 MHz, CDCl3):
d
22.0, 22.8, 23.4, 28.3, 28.9,
E1RED¼ꢀ0.83 V, ER2ED¼ꢀ0.98 V. Anal. Calcd for C25H20N4: C, 79.76; H,
109.4, 117.9, 122.6, 122.7, 124.1, 125.3, 128.2, 129.0, 134.9, 136.8,
137.9, 141.7, 145.4, 163.5; MS (DEI): m/z (%): 466 (M)þ (31), 451 (93),
423 (100), 357 (39), 278 (95), 264 (91), 238 (89), 220 (25), 186 (87),
5.35; N, 14.88. Found: C, 79.69; H, 5.25; N, 14.96.
4.3. Reduction of 4H-imidazo-[1,2-a]-pyridine (9a) to 1-
azaindolizine (10a)
170 (43), 91 (35), 43 (27); IR (ATR): 1658, 1604, 1504, 1463 cmꢀ1
;
UV–vis (CHCl3) lmax (log 3): 270 (4.2), 464 (3.9), 492 (4.0), 531
(3.9) nm; CV: ER1ED¼ꢀ1.01 V, ER2ED¼ꢀ1.12 V. Anal. Calcd for
Derivative 9a (168 mg, 0.5 mmol) was dissolved in 15 ml of ac-
etone or THF. While stirring the red-violet solution, 1 equiv of
a 0.06 M aqueous solution of sodium dithionite was added. The
colour of the reaction mixture changes to yellow brown, which
indicates the formation of the 1-azaindolizine 10a. The reduction
product was isolated by removing the organic solvents under re-
duced pressure, extracting the indolizine from the aqueous layer
with methylene chloride, drying the organic layer with anhydrous
sodium sulfate and evaporating to dryness.
C
31H38N4: C, 79.78; H, 8.21; N, 12.01. Found: C, 79.65; H, 8.20;
N, 12.15.
4.2.4. 2,3-Bis-(2,4,6-trimethylphenylimino)-2H-imidazo-[1,2-a]-
pyridine (9d)
Yield: 160 mg (21%), black, metallic shining crystals, mp 101–
103 ꢂC; 1H NMR (400 MHz, CDCl3):
d 2.22 (s, 3H), 2.29 (s, 6H), 2.37
(s, 3H), 2.69 (s, 6H), 6.48 (d, 3J¼8.4 Hz, 1H), 7.10 (s, 2H), 7.1–7.2 (m,
2H), 7.26 (s, 2H), 7.97 (d, 3J¼8.0 Hz, 1H); 13C NMR (100 MHz,
4.3.1. N2,N3-Di-p-tolyl-imidazo-[1,2-a]-pyridine-2,3-diamine (10a)
CDCl3):
d 18.5, 18.9, 20.7, 20.9, 21.4, 109.0, 113.7, 115.8, 125.3, 128.2,
Yield: 100%, yellow brown powder; 1H NMR (250 MHz, acetone-
128.6, 129.0, 129.5, 132.3, 133.0, 135.4, 138.0, 140.4, 140.7, 143.3,
145.3, 147.1, 156.8, 158.3, 162.2; MS (DEI): m/z (%): 381 (Mꢀ1)þ (4),
234 (19), 228 (1), 206 (17), 161 (55), 91 (43), 77 (31), 67 (100), 58
(40), 39 (66), 28 (78); IR (ATR): 1651, 1599, 1499, 1476 cmꢀ1; UV–
d6):
d
2.21 (s, 6H), 6.81 (d, 3J¼8.5 Hz, 4H), 6.9–7.2 (m, 7H), 7.57 (t,
1H); MS (DEI): m/z (%): 328 (M)þ (85), 268 (67), 237 (51), 220 (95),
205 (100), 133 (51), 118 (42), 107 (81), 91 (76), 71 (64), 42 (78); UV–
vis (THF) lmax (log 3): 375 (3.9) nm; Fluorescence (THF, 382 nm)
lmax,em: 470 nm. Anal. Calcd for C21H20N4: C, 76.80; H, 6.14; N,17.06.
Found: C, 76.78; H, 6.23; N, 16.99.
vis (CHCl3) lmax (log 3): 388 (3.7), 398 (3.7), 481 (3.9), 517 (4.0), 556
(3.9) nm; CV: ER1ED¼ꢀ0.88 V, ER2ED¼ꢀ1.03 V. Anal. Calcd for
C
25H26N4: C, 78.50; H, 6.85; N, 14.65. Found: C, 78.45; H, 6.93; N,
14.62.
Acknowledgements
4.2.5. 2,3-Bis-(4-tolylimino)-2H-imidazo-[1,2-a]-5-methyl-
pyridine (9e)
We thank the Deutsche Forschungsgemeinschaft (DFG) for the
generous support.
Yield: 238 mg (35%), black violet solid; 1H NMR (400 MHz,
CDCl3):
d
2.17 (s, 3H), 2.25 (s, 3H), 2.35 (s, 3H), 6.65 (d, 3J¼9.0 Hz,
2H), 6.83 (d, 3J¼7.0 Hz, 1H), 6.87 (d, 3J¼7.0 Hz, 1H), 7.05 (t,
3J¼8.5 Hz, 1H), 7.20 (d, 3J¼8.2 Hz, 2H), 7.65 (d, 3J¼8.2 Hz, 2H), 7.74
References and notes
(d, 3J¼8.2 Hz, 2H); 13C NMR (100 MHz, CDCl3):
d 21.2, 30.9, 110.3,
1. Burgess, K.; Gibbs, R. U.S. Patent 6,340,750, 2002; Tsien, R. Y.; Gonzales, J. E. U.S.
Patent 7,087,416, 2006.
2. Langhals, H. U.S. Patent 5,693,808, 1997; U.S. Patent 5,508,137, 1996.
3. Auberson, Y. Patent No. WO 2003/074519, 2003.
4. Phillips, E. D. Patent No. WO 1999/048961, 1999; U.S. Patent 6,734,235, 2004.
5. Atzrodt, J.; Brandenburg, J.; Ka¨pplinger, C.; Beckert, R.; Gu¨nther, W.; Go¨rls, H.;
Fabian, J. J. Prakt. Chem. 1997, 339, 729.
116.0, 119.9, 120.2, 125.3, 128.5, 129.3, 129.4, 129.7, 130.4, 133.0,
135.7, 139.8, 141.3, 141.7, 142.6, 146.1; MS (DEI): m/z (%): 340 (M)þ
(2), 339 (Mꢀ1)þ (4), 338 (Mꢀ2)þ (12), 206 (16), 149 (21), 133 (41),
106 (100), 77 (23); IR (ATR): 1597, 1575, 1457 cmꢀ1; UV–vis (CHCl3)
lmax (log
22H20N4: C, 77.62; H, 5.92; N, 16.46. Found: C, 77.49; H, 5.91;
N, 16.60.
3): 539 (3.9), 575 (4.0), 616 (3.9) nm. Anal. Calcd for
6. Matschke, M.; Beckert, R. Molecules 2007, 12, 723.
C
7. Matschke, M.; Ka¨pplinger, C.; Beckert, R. Tetrahedron 2006, 60, 8586.
8. Blumhoff, J.; Beckert, R.; Walther, D.; Rau, S.; Rudolph, M.; Go¨rls, H.; Plass, W.
Eur. J. Inorg. Chem. 2007, 3, 481.
9. Matschke, M.; Knop, K.; Beckert, R. Struct. Chem., 2008. doi:10.1007/s 11224-
008-9294-y
10. Beckert, R.; Hippius, C.; Gebauer, T.; Sto¨ckner, F.; Lu¨ digk, C.; Weiß, D.; Raabe, D.;
Gu¨nther, W.; Go¨rls, H. Z. Naturforsch. 2006, 61b, 437.
11. Mu¨ ller, D.; Beckert, R.; Weston, J.; Gu¨nther, W.; Go¨rls, H.; Friedrich, M. Eur. J. Org.
Chem. 2001, 4551.
12. Bauer, K. Chem. Ber. 1950, 83, 10.
13. Adler, A. D.; Longo, F.; Shergalis, W. J. Am. Chem. Soc. 1964, 86, 3145.
14. Adler, A. D.; Longo, F.; Finarelli, J.; Goldmacher, J.; Assour, J.; Korsakoff, L. J. Org.
Chem. 1967, 32, 476.
15. Sen, R.; Sinha, N. J. Am. Chem. Soc. 1923, 45, 2984.
16. Jiao, G.; Thoresen, L.; Burgess, K. J. Am. Chem. Soc. 2003, 125, 14668.
17. Staab, H.; Sauer, M. Liebigs Ann. Chem. 1984, 4, 742.
18. Murdock, K. C.; Child, R. G.; Fabio, P. F.; Angier, R. B.; Wallace, R. E.; Durr, F. E.;
Citarella, R. V. J. Med. Chem. 1979, 22, 1024.
19. Sasaki, H.; Ueno, A.; Osa, T. Bull. Chem. Soc. Jpn. 1988, 61, 2321.
20. Witkop, B.; Fiedler, H. Liebigs Ann. Chem. 1947, 558, 91.
21. Ito, S.; Zakeeruddin, S. M.; Humphry-Baker, R.; Liska, P.; Charvet, R.; Comte, P.;
Nazeeruddin, M. K.; Pechy, P.; Takata, M.; Miura, H.; Uchida, S.; Gra¨tzel, M. Adv.
Mater. 2006, 9, 1202.
4.2.6. 2,3-Bis-(4-tolylimino)-2H-imidazo-[1,2-a]-6-nitro-
pyridine (9f)
Yield: 200 mg (27%), dark red solid; 1H NMR (250 MHz, CDCl3):
d
2.28 (s, 3H), 2.41 (s, 3H), 6.83 (d, 3J¼8.0 Hz, 2H), 6.9–7.3 (m, 7H),
7.54 (d, 3J¼8.5 Hz, 1H), 7.91 (d, 3J¼8.3 Hz, 1H); 13C NMR (62 MHz,
CDCl3):
d 20.9, 21.3, 107.3, 117.5, 120.3, 120.9, 129.3, 129.5, 129.9,
130.6, 132.4, 134.7, 136.6, 146.7, 147.3, 154.9, 160.7; MS (DEI): m/z
(%): 371 (M)þ (2), 370 (Mꢀ1)þ (4), 324 (26), 290 (98), 205 (93), 106
(71), 91 (100), 72 (67); IR (ATR): 1638, 1595, 1558, 1505, 1291 cmꢀ1
;
UV–vis (CHCl3) lmax (log 3): 463 (3.7), 494 (3.9), 534 (3.8) nm. Anal.
Calcd for C21H17N5O2: C, 67.91; H, 4.61; N, 18.86. Found: C, 67.85; H,
4.54; N, 18.90.
4.2.7. 2,3-Bis-(4-tolylimino)-2H-imidazo-[1,2-a]-isoquinoline (9g)
Yield: 410 mg (55%), dark red solid, mp>160 ꢂC (decomp.); 1H
NMR (250 MHz, CDCl3):
d 2.38 (s, 3H), 2.39 (s, 3H), 6.64 (d,
22. Gebauer, T.; Beckert, R.; Weiß, D.; Knop, K.; Kapplinger, C.; Gorls, H. Chem.
¨
¨
3J¼7.2 Hz, 1H), 7.15–7.25 (m, 3H), 7.29 (t, 3J¼7.2 Hz, 1H), 7.39 (d,
Commun. 2004, 1860.
23. Atzrodt, J.; Beckert, R.; Gu¨nther, W.; Go¨rls, H. Eur. J. Org. Chem. 2000, 8, 1661.
24. Langer, P.; Wuckelt, J.; Do¨ring, M.; Go¨rls, H. Eur. J. Org. Chem. 2001, 1503.
25. Ollis, W. D.; Ramsden, C. A.; Sanforth, S. P. Tetrahedron 1985, 41, 2239.
26. Katritzky, A. R.; Burton, R. D.; Shipkova, P. A.; Qi, M.; Watson, C. H.; Eyler, J.
J. Chem. Soc., Perkin Trans. 2 1998, 835.
27. Brandenburg, J.; Ka¨pplinger, C.; Beckert, R. Synthesis 1996, 1302.
28. Malhotra, S. S.; Whiting, M. C. J. Chem. Soc. 1960, 3812.
29. Mu¨ller, D.; Beckert, R.; Go¨rls, H. Synthesis 2001, 4, 601.
3J¼8.0 Hz, 2H), 7.55 (d, 3J¼8.0 Hz, 2H), 7.58 (d, 3J¼8.0 Hz, 2H), 7.71
(t, 3J¼6.8 Hz, 1H), 7.79 (d, 3J¼7.2 Hz, 1H), 8.48 (d, 3J¼7.6 Hz, 1H); 13
C
NMR (62 MHz, CDCl3):
d 21.0, 21.5, 109.3, 121.4, 122.1, 125.3, 126.7,
127.1,127.2,128.1,128.2,129.1,129.3,134.0,136.2,143.4,145.2,145.9,
151.3, 157.5, 162.6; MS (DEI): m/z (%): 376 (M)þ (11), 375 (21), 361
(20), 285 (17), 268 (14), 258 (31), 128 (60), 106 (54), 91 (100); IR